ArticleSpringerPlus2016

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.

Graham R Foster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.